Skip to main content

Table 4 Baseline and change scores for fasting and OGTT parameters in STRRIDE-PD by group

From: Differential Effects of Amount, Intensity, and Mode of Exercise Training on Insulin Sensitivity and Glucose Homeostasis: A Narrative Review

 

Low amount/moderate intensity (n = 35)

High amount/moderate intensity (n = 40)

High amount/vigorous intensity (n = 38)

Clinical lifestyle

(n = 37)

 

Baseline

Change

p

Baseline

Change

p

Baseline

Change

p

Baseline

Change

p

Fasting parameters

Glucose (mmol/L)

5.87 (0.6)

0.05 (0.3)

NS

5.91 (0.5)

− 0.07 (0.4)

NS

5.79 (0.5)

0.06 (0.4)

NS

5.86 (0.6)

− 0.32 (0.4)

***

Insulin (pmol/L)

48.4 (24)

− 5.4 (16)

NS

45.3 (31)

− 6.4 (24)

NS

49.8 (44)

− 9.3 (24)

*

50.0 (28)

− 21.5 (22)

***

HOMA-IR

1.9 (1.0)

− 0.2 (0.7)

NS

1.8 (1.3)

− 0.3 (1.0)

NS

2.0 (1.9)

− 0.4 (1.0)

*

2.0 (1.2)

− 0.9 (0.9)

***

LP-IRa

54.5 (22.4)

− 0.6 (13.9)

NS

55.2 (22.6)

− 4.4 (16.2)

NS

55.2 (22.4)

− 4.4 (8.2)

**

57.1 (18.3)

− 12.4 (14.1)

***

DRIa

37.9 (16.8)

− 0.6 (10.0)

NS

38.5 (18.3)

− 1.4 (11.5)

NS

39.1 (17.1)

− 2.8 (8.2)

*

39.2 (16.8)

− 8.3 (10.4)

***

OGTT parameters

Glucose AUC (mmol/L × 120 min)

1039 (219)

− 49 (143)

NS

1042 (192)

− 73 (123)

***

1031 (211)

− 22 (103)

NS

1050 (232)

− 96 (132)

***

Insulin AUC (pmol/L × 120 min)

955 (645)

− 166 (330)

**

990 (666)

− 264 (452)

***

1135 (999)

− 246 (452)

**

982 (527)

− 348 (350)

***

Matsuda Index

5.14 (3.2)

1.08 (1.7)

***

5.55 (3.5)

1.35 (2.7)

**

5.25 (3.0)

1.38 (2.4)

***

4.99 (3.3)

3.98 (3.9)

***

  1. Data presented as means (SD)
  2. AUC, area under the curve; DRI, Diabetes Risk Index; HOMA, homeostatic model assessment [(fasting glucose x fasting insulin)/22.5]; NS, not significant; OGTT, oral glucose tolerance test; LP-IR, Lipoprotein Insulin Resistance Index
  3. *p < 0.05; **p < 0.01; ***p < 0.001
  4. aLP-IR and DRI sample sizes are: Low/Mod (n = 42); High/Mod (n = 45); High/Vig (n = 40); CL (n = 43)